Internal Medicine, Hematology & Oncology · Anderson, SC
NPI
1982670147
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2000 E Greenville St, Ste 5000
Anderson, SC, 29621
Phone (864) 224-5765
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.0M
379,071 services
Medicare patients, 2024
847
Average age 76
Drug cost, 2024
$10.0M
3,002 prescriptions
Company payments, 2025
$2,826
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John Doster was code J1439 (injection, ferric carboxymaltose, 1 mg), 118,500 times for 75 patients. In total John Doster billed 379,071 services in 155 codes, and Medicare paid $6.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 118,500 | 75 | $0.86 | $102K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 37,200 | 24 | $44.31 | $1.6M |
| J1453 Injection, fosaprepitant, 1 mg | Office | 20,550 | 31 | $0.11 | $2,219 |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 18,096 | 12 | $0.05 | $909 |
| J0897 Injection, denosumab, 1 mg | Office | 14,280 | 79 | $20.45 | $292K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,498 | 71 | $0.09 | $400 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,510 | 56 | $0.70 | $2,463 |
| 85025 Blood Count | Office | 2,912 | 759 | $7.56 | $22K |
| 80053 Clinical Chemistry | Office | 2,428 | 689 | $10.27 | $25K |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 2,357 | 23 | $3.46 | $8,145 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 2,288 | 23 | $0.07 | $166 |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 1,890 | 11 | $31.45 | $59K |
| 83615 Clinical Chemistry | Office | 1,816 | 483 | $5.89 | $11K |
| J9190 Injection, fluorouracil, 500 mg | Office | 1,466 | 24 | $2.23 | $3,275 |
| 83735 Clinical Chemistry | Office | 1,360 | 392 | $6.50 | $8,846 |
By year: 2022 $5.3M for 360,290 services; 2023 $5.4M for 351,823 services; 2024 $6.0M for 379,071 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,912 | 759 | $7.56 | $22K |
| 80053 Clinical Chemistry | 2,428 | 689 | $10.27 | $25K |
| 83615 Clinical Chemistry | 1,816 | 483 | $5.89 | $11K |
| 83735 Clinical Chemistry | 1,360 | 392 | $6.50 | $8,846 |
| 36415 Venipuncture Blood Collection | 557 | 315 | $8.62 | $4,803 |
| 86300 Immunoassay | 426 | 203 | $20.24 | $8,621 |
| 83540 Clinical Chemistry | 411 | 212 | $6.28 | $2,582 |
| 83550 Clinical Chemistry | 409 | 213 | $8.49 | $3,473 |
| 82728 Clinical Chemistry | 404 | 207 | $13.24 | $5,347 |
| 82378 Clinical Chemistry | 374 | 111 | $18.20 | $6,806 |
Medicare prescription drug claims, 2024
In 2024, the drug John Doster prescribed most often to Medicare patients was Anastrozole, with 437 prescriptions and refills. In total John Doster wrote 3,002 Medicare prescriptions that cost $10.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 437 | 1,159 | 139 | $9,658 |
| Prednisone Generic | 209 | 213 | 57 | $658 |
| Abiraterone Acetate Generic | 164 | 165 | 24 | $422K |
| Ondansetron Hcl Generic | 155 | 155 | 76 | $1,475 |
| Revlimid Lenalidomide | 90 | 90 | 11 | $1.4M |
| Levothyroxine Sodium Generic | 80 | 175 | 25 | $835 |
| Dexamethasone Generic | 79 | 96 | 30 | $1,253 |
| Oxycodone Hcl Generic | 75 | 75 | 44 | $1,799 |
| Letrozole Generic | 74 | 104 | 11 | $1,649 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 68 | 68 | 36 | $1,642 |
| Lenalidomide Generic | 65 | 65 | 13 | $920K |
| Acyclovir Generic | 62 | 80 | 18 | $1,258 |
| Ibrance Palbociclib | 61 | 61 | Under 11 | $946K |
| Xtandi Enzalutamide | 57 | 57 | Under 11 | $783K |
| Promethazine Hcl Generic | 57 | 57 | 27 | $157 |
Brand drugs: - claims; generic drugs: 2,272 claims; opioid claims: 212.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John Doster $2,826 ($2,826 in general payments such as food, travel and fees) from 44 companies. The largest payer was Daiichi Sankyo Inc. with $256.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 11 | $256 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $230 |
| Pfizer Inc. PFE | 13 | $212 |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $208 |
| Janssen Biotech, Inc. JNJ | 8 | $198 |
| Eisai Inc. 4523.T | 6 | $145 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $129 |
| Celgene Corporation BMY | 5 | $109 |
| Abbvie Inc. ABBV | 5 | $93.98 |
| Exelixis Inc. EXEL | 4 | $88.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.